
Please try another search
Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally. It also develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Mikael Havsjo | 69 | 2011 | Director |
Artur Aira | 58 | 2018 | Chairman |
Neven Zoric | 46 | 2020 | Director |
Joakim Granemo | 39 | 2022 | CEO & Director |
Ulrica Karlsson | 56 | 2012 | CFO & Director |
Tobias Schön | - | 2023 | Director |
Helene Olsson | - | - | Director of Cybergene AB |
Mikael Kubista | 64 | 2024 | Director |
Claes Gustafsson | - | - | Director of Techtum Lab AB |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review